Nicolas Hoertel, MD, MPH, PhD
@hoerteln
MCU-PH à Université de Paris, INSERM, GHU APHP.Centre, Hôpital Corentin-Celton
MD, MPH, PhD (Assoc. Prof.) in Psychiatry/Neurosciences
Opinions are my own
ID: 1423709913654702084
06-08-2021 18:18:05
277 Tweet
1,1K Followers
143 Following
🔥 Latest systematic review and meta-analysis on #fluvoxamine and #Covid-19 ➡️ Fluvoxamine 100 mg bid is well tolerated and significantly associated with ⬇️ #mortality, #hospitalization, and composite of hospitalization/ER visits, but not at lower dose. sciencedirect.com/science/articl…
"Une enquête de SantépubliqueFrance a montré une hausse des épisodes de #dépression en 2021 dans toute la population ; Avec 1 #jeune sur 5 présentant des troubles dépressifs, la part des 18-24 ans touchés a quasiment doublé depuis 2017" | Pascale Santi lemonde.fr/sciences/artic…
Impact of lithium on mortality among #olderadults with major #psychiatric disorders: A 5-year prospective multicenter study tandfonline.com/doi/abs/10.108… Nicolas Hoertel, MD, MPH, PhD
👍 paper François Montastruc, MD, PhD Compared to AEs recorded in clinicaltrials.gov, 41.5% of serious AEs and 39% of non-serious AEs were not reported in the papers. The majority = psychiatric events + cardiovascular events. 94% of those = from esketamine groups. cambridge.org/core/journals/…
🆕️⚡️Systematic review & meta-analysis #JAC 9 RCTs ~ 30K In a predominantly immunized population of COVID-19 outpatients, molnupiravir has no effect on mortality, probably none on ‘hospitalization or death’ and effects on symptom resolution are uncertain academic.oup.com/jac/advance-ar…